Andra Ap Fonden Zai Lab LTD Transaction History

Andra Ap Fonden

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$30.21 - $48.1 $504,507 - $803,270	16,700 Added 42.93%	55,600 $1.85 Million
Q4 2022 Feb 13, 2023	BUY	$22.28 - $38.71 $588,192 - $1.02 Million	26,400 Added 211.2%	38,900 $1.19 Million
Q3 2022 Nov 14, 2022	SELL	$34.2 - $51.69 $1.07 Million - $1.62 Million	-31,400 Reduced 71.53%	12,500 $428,000
Q2 2022 Aug 15, 2022	BUY	$23.14 - $49.68 $277,680 - $596,160	12,000 Added 37.62%	43,900 $1.52 Million
Q4 2021 Feb 15, 2022	BUY	$54.9 - $105.21 $1.41 Million - $2.7 Million	25,700 Added 414.52%	31,900 $2.01 Million
Q2 2021 Aug 16, 2021	BUY	$125.11 - $180.0 $187,665 - $270,000	1,500 Added 31.91%	6,200 $1.1 Million
Q1 2021 May 17, 2021	SELL	$126.27 - $191.71 $669,231 - $1.02 Million	-5,300 Reduced 53.0%	4,700 $627,000
Q4 2020 Feb 12, 2021	BUY	$81.94 - $135.34 $368,730 - $609,030	4,500 Added 81.82%	10,000 $1.35 Million
Q3 2020 Nov 12, 2020	BUY	$73.3 - $89.48 $403,150 - $492,140	5,500 New	5,500 $457,000

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.59B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Andra Ap Fonden, based on Form 13F filings with the SEC.

Stay updated on Andra Ap Fonden with notifications on news.